K2 Principal Fund’s Veraxa Biotech AG Warrants VRXAW Stock Holding History

K2 Principal Fund’s Portfolio VRXAW Stock Details VRXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.3K	Buy	+154,948	New	+$16.2K	﹤0.01%	442

Other funds holding VRXAW

Yorkville Advisors Global Mountainside, New Jersey $133M AUM 33.08% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $18B AUM 27.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Kepos Capital New York $80.4M AUM 3.91% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 22.91% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return

K2 Principal Fund's VRXAW Position: Q3 2026 in Review

K2 Principal Fund opened a new position in Veraxa Biotech AG Warrants (VRXAW) in Q3 2026: 154,948 shares worth $9.3K. The stake represents ﹤0.01% of the portfolio and ranks #442 among its holdings.

16 funds tracked by Wall St. Rank hold VRXAW as of Q3 2026.

K2 Principal Fund held 154,948 shares of Veraxa Biotech AG Warrants worth $9.3K as of Q3 2026.
Veraxa Biotech AG Warrants was a new K2 Principal Fund position in Q3 2026.
Veraxa Biotech AG Warrants made up ﹤0.01% of K2 Principal Fund's portfolio in Q3 2026, its #442 holding.
16 funds tracked by Wall St. Rank held Veraxa Biotech AG Warrants as of Q3 2026.

Based on K2 Principal Fund's 13F filing for Q3 2026, filed 13 Nov 2026.